These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34172602)

  • 1. Reliability of Quantitative 18F-FDG PET/CT Imaging Biomarkers for Classifying Early Response to Chemoradiotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer.
    Horn KP; Thomas HMT; Vesselle HJ; Kinahan PE; Miyaoka RS; Rengan R; Zeng J; Bowen SR
    Clin Nucl Med; 2021 Nov; 46(11):861-871. PubMed ID: 34172602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of a block sequential regularized expectation maximization reconstruction algorithm in 18F-FDG PET/CT studies.
    Sah BR; Stolzmann P; Delso G; Wollenweber SD; Hüllner M; Hakami YA; Queiroz MA; Barbosa FG; von Schulthess GK; Pietsch C; Veit-Haibach P
    Nucl Med Commun; 2017 Jan; 38(1):57-66. PubMed ID: 27755394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence for detecting small FDG-positive lung nodules in digital PET/CT: impact of image reconstructions on diagnostic performance.
    Schwyzer M; Martini K; Benz DC; Burger IA; Ferraro DA; Kudura K; Treyer V; von Schulthess GK; Kaufmann PA; Huellner MW; Messerli M
    Eur Radiol; 2020 Apr; 30(4):2031-2040. PubMed ID: 31822970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of Bayesian penalized likelihood reconstruction for improving lesion conspicuity of malignant lung tumors on
    Kurita Y; Ichikawa Y; Nakanishi T; Tomita Y; Hasegawa D; Murashima S; Hirano T; Sakuma H
    Ann Nucl Med; 2020 Apr; 34(4):272-279. PubMed ID: 32060780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved detection of in-transit metastases of malignant melanoma with BSREM reconstruction in digital [
    Liberini V; Messerli M; Husmann L; Kudura K; Grünig H; Maurer A; Skawran S; Orita E; Pizzuto DA; Deandreis D; Dummer R; Mangana J; Mihic-Probst D; Rupp N; Huellner MW
    Eur Radiol; 2021 Oct; 31(10):8011-8020. PubMed ID: 33768288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of different image reconstructions on PET quantification in non-small cell lung cancer: a comparison of adenocarcinoma and squamous cell carcinoma.
    Messerli M; Kotasidis F; Burger IA; Ferraro DA; Muehlematter UJ; Weyermann C; Kenkel D; von Schulthess GK; Kaufmann PA; Huellner MW
    Br J Radiol; 2019 Apr; 92(1096):20180792. PubMed ID: 30673302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of time of flight and point spread function on quantitative parameters of lung lesions in
    Huang K; Feng Y; Liang W; Li L
    BMC Med Imaging; 2021 Nov; 21(1):169. PubMed ID: 34773998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG PET early response evaluation of locally advanced non-small cell lung cancer treated with concomitant chemoradiotherapy.
    Usmanij EA; de Geus-Oei LF; Troost EG; Peters-Bax L; van der Heijden EH; Kaanders JH; Oyen WJ; Schuurbiers OC; Bussink J
    J Nucl Med; 2013 Sep; 54(9):1528-34. PubMed ID: 23864719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity analysis of FDG PET tumor voxel cluster radiomics and dosimetry for predicting mid-chemoradiation regional response of locally advanced lung cancer.
    Duan C; Chaovalitwongse WA; Bai F; Hippe DS; Wang S; Thammasorn P; Pierce LA; Liu X; You J; Miyaoka RS; Vesselle HJ; Kinahan PE; Rengan R; Zeng J; Bowen SR
    Phys Med Biol; 2020 Oct; 65(20):205007. PubMed ID: 33027064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local and regional treatment response by
    van Diessen JNA; La Fontaine M; van den Heuvel MM; van Werkhoven E; Walraven I; Vogel WV; Belderbos JSA; Sonke JJ
    Radiother Oncol; 2020 Feb; 143():30-36. PubMed ID: 31767474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative and Qualitative Improvement of Low-Count [
    Seo Y; Khalighi MM; Wangerin KA; Deller TW; Wang YH; Jivan S; Kohi MP; Aggarwal R; Flavell RR; Behr SC; Evans MJ
    Mol Imaging Biol; 2020 Feb; 22(1):208-216. PubMed ID: 30993558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial.
    Salavati A; Duan F; Snyder BS; Wei B; Houshmand S; Khiewvan B; Opanowski A; Simone CB; Siegel BA; Machtay M; Alavi A
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1969-1983. PubMed ID: 28689281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability and Repeatability of Quantitative Uptake Metrics in
    Zhuang M; García DV; Kramer GM; Frings V; Smit EF; Dierckx R; Hoekstra OS; Boellaard R
    J Nucl Med; 2019 May; 60(5):600-607. PubMed ID: 30389824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early assessment of metabolic response by 18F-FDG PET during concomitant radiochemotherapy of non-small cell lung carcinoma is associated with survival: a retrospective single-center study.
    Yossi S; Krhili S; Muratet JP; Septans AL; Campion L; Denis F
    Clin Nucl Med; 2015 Apr; 40(4):e215-21. PubMed ID: 25546211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of [
    Liu Y; Gao MJ; Zhou J; Du F; Chen L; Huang ZK; Hu JB; Lou C
    BMC Med Imaging; 2021 Sep; 21(1):133. PubMed ID: 34530768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Penalized-Likelihood Estimation Reconstruction on a Digital Time-of-Flight PET/CT Scanner for
    Lindström E; Sundin A; Trampal C; Lindsjö L; Ilan E; Danfors T; Antoni G; Sörensen J; Lubberink M
    J Nucl Med; 2018 Jul; 59(7):1152-1158. PubMed ID: 29449445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced count pediatric whole-body
    Alves VPV; Ata NA; MacLean J; Sharp SE; Li Y; Brady S; Trout AT
    Pediatr Radiol; 2024 Jan; 54(1):170-180. PubMed ID: 37962603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial.
    Nestle U; Schimek-Jasch T; Kremp S; Schaefer-Schuler A; Mix M; Küsters A; Tosch M; Hehr T; Eschmann SM; Bultel YP; Hass P; Fleckenstein J; Thieme A; Stockinger M; Dieckmann K; Miederer M; Holl G; Rischke HC; Gkika E; Adebahr S; König J; Grosu AL;
    Lancet Oncol; 2020 Apr; 21(4):581-592. PubMed ID: 32171429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer: A Phase 2 Clinical Trial.
    Kong FM; Ten Haken RK; Schipper M; Frey KA; Hayman J; Gross M; Ramnath N; Hassan KA; Matuszak M; Ritter T; Bi N; Wang W; Orringer M; Cease KB; Lawrence TS; Kalemkerian GP
    JAMA Oncol; 2017 Oct; 3(10):1358-1365. PubMed ID: 28570742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.